Tsuda M - Search Results

1

Influence of ensitrelvir or nirmatrelvir/ritonavir on tacrolimus clearance in kidney transplant recipients: a single-center case series.

Naganawa H, Katada Y, Nakagawa S, Umemura K, Ishimura H, Kajiwara M, Endo H, Sugimoto M, Katsube Y, Kotani K, Ohta S, Hira D, Tsuda M, Kita Y, Kobayashi T, Terada T. Naganawa H, et al. Among authors: tsuda m. J Pharm Health Care Sci. 2024 Jul 10;10(1):37. doi: 10.1186/s40780-024-00361-x. J Pharm Health Care Sci. 2024. PMID: 38987842 Free PMC article.

2

Prediction of glycylsarcosine transport in Caco-2 cell lines expressing PEPT1 at different levels.

Irie M, Terada T, Tsuda M, Katsura T, Inui K. Irie M, et al. Among authors: tsuda m. Pflugers Arch. 2006 Apr;452(1):64-70. doi: 10.1007/s00424-005-0005-x. Epub 2005 Nov 10. Pflugers Arch. 2006. PMID: 16283203

3

Transport characteristics of a novel peptide transporter 1 substrate, antihypotensive drug midodrine, and its amino acid derivatives.

Tsuda M, Terada T, Irie M, Katsura T, Niida A, Tomita K, Fujii N, Inui K. Tsuda M, et al. J Pharmacol Exp Ther. 2006 Jul;318(1):455-60. doi: 10.1124/jpet.106.102830. Epub 2006 Apr 5. J Pharmacol Exp Ther. 2006. PMID: 16597710

4

Molecular cloning, functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1.

Terada T, Masuda S, Asaka J, Tsuda M, Katsura T, Inui K. Terada T, et al. Among authors: tsuda m. Pharm Res. 2006 Aug;23(8):1696-701. doi: 10.1007/s11095-006-9016-3. Pharm Res. 2006. PMID: 16850272

5

Oppositely directed H+ gradient functions as a driving force of rat H+/organic cation antiporter MATE1.

Tsuda M, Terada T, Asaka J, Ueba M, Katsura T, Inui K. Tsuda M, et al. Am J Physiol Renal Physiol. 2007 Feb;292(2):F593-8. doi: 10.1152/ajprenal.00312.2006. Epub 2006 Oct 17. Am J Physiol Renal Physiol. 2007. PMID: 17047166 Free article.

6

Identification of essential histidine and cysteine residues of the H+/organic cation antiporter multidrug and toxin extrusion (MATE).

Asaka J, Terada T, Tsuda M, Katsura T, Inui K. Asaka J, et al. Among authors: tsuda m. Mol Pharmacol. 2007 Jun;71(6):1487-93. doi: 10.1124/mol.106.032938. Epub 2007 Feb 27. Mol Pharmacol. 2007. PMID: 17327464

7

Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells.

Tsuda M, Terada T, Ueba M, Sato T, Masuda S, Katsura T, Inui K. Tsuda M, et al. J Pharmacol Exp Ther. 2009 Apr;329(1):185-91. doi: 10.1124/jpet.108.147918. Epub 2009 Jan 22. J Pharmacol Exp Ther. 2009. PMID: 19164462

8

Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin.

Tsuda M, Terada T, Mizuno T, Katsura T, Shimakura J, Inui K. Tsuda M, et al. Mol Pharmacol. 2009 Jun;75(6):1280-6. doi: 10.1124/mol.109.056242. Epub 2009 Mar 30. Mol Pharmacol. 2009. PMID: 19332510

9

Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients.

Toyama K, Yonezawa A, Tsuda M, Masuda S, Yano I, Terada T, Osawa R, Katsura T, Hosokawa M, Fujimoto S, Inagaki N, Inui K. Toyama K, et al. Among authors: tsuda m. Pharmacogenet Genomics. 2010 Feb;20(2):135-8. doi: 10.1097/FPC.0b013e328335639f. Pharmacogenet Genomics. 2010. PMID: 20016398 Clinical Trial.

10

Reduced renal clearance of a zwitterionic substrate cephalexin in MATE1-deficient mice.

Watanabe S, Tsuda M, Terada T, Katsura T, Inui K. Watanabe S, et al. Among authors: tsuda m. J Pharmacol Exp Ther. 2010 Aug;334(2):651-6. doi: 10.1124/jpet.110.169433. Epub 2010 May 19. J Pharmacol Exp Ther. 2010. PMID: 20484555

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,020 results

Search Page

Filters